Pavel Hayl Lugo-Fabres

9PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsNeural engineeringMolecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 04, 2026
Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model.

|Apr 25, 2025
Alginate-Gelatin Hydrogel Scaffold Model for Hypoxia Induction in Glioblastoma Embedded Spheroids.

Janette Del Rocío Aguilera-Marquez, Alejandro Manzanares-Guzmán, Lorena García-Uriostegui

|Feb 13, 2025
Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (Potamotrygon spp.) as a Drug Carrier in Glioblastoma Cancer Cells.

Alejandro Manzanares-Guzmán, Andrea C Alfonseca-Ladrón de Guevara, Elia Reza-Escobar

|Mar 27, 2024
vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target.

Alejandro Manzanares-Guzmán, Pavel H Lugo-Fabres, Tanya A Camacho-Villegas

|Sep 28, 2023
Embedded Living HER2+ Cells in a 3D Gelatin-Alginate Hydrogel as an In Vitro Model for Immunotherapy Delivery for Breast Cancer.

G Tonantzin De Dios-Figueroa, Janette Del Rocío Aguilera-Márquez, Lorena García-Uriostegui

|Nov 11, 2022
3D Cell Culture as Tools to Characterize Rheumatoid Arthritis Signaling and Development of New Treatments.

Jessica Andrea Badillo-Mata, Tanya Amanda Camacho-Villegas, Pavel Hayl Lugo-Fabres

Pageof 2

Frequent Collaborators

8 joint publications

Tanya Amanda Camacho-Villegas

2 joint publications

Alexei Licea-Navarro

2 joint publications

Lorena García-Uriostegui

2 joint publications

Alejandro Canales-Aguirre